MedPath

Study on using inheritance characters test for medication in new schizophrenia patients in northern India to enhance treatment effectiveness

Phase 3
Conditions
Health Condition 1: F209- Schizophrenia, unspecified
Registration Number
CTRI/2024/06/069270
Lead Sponsor
Dr Amrita Kumari Pandey
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.ICD-10 or 11 criteria for schizophrenia

2.Positive and Negative Syndrome Scale (PANSS) more than 60 score

3.Patient or legally authorized representative willing to give informed consent

4.Two generations of the patient living in northern India

5.Schizophrenic patients who have not received any psychotropics

Exclusion Criteria

1.Concurrent substance use disorders

2.Neurological conditions

3.Other comorbid axis I psychiatric diagnoses

4.Severe unstable organic illnesses

5.Not able to give consent

6.Pregnant or lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath